Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Synlogic Inc
(NQ:
SYBX
)
1.650
+0.030 (+1.85%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Synlogic Inc
< Previous
1
2
3
4
5
Next >
12 Health Care Stocks Moving In Wednesday's After-Market Session
November 30, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
November 28, 2022
On Monday, 79 companies reached new 52-week lows.
Via
Benzinga
Synlogic Touts Positive Data From Rare Inherited Disorder Trial, Pivotal Study To Start Next Year
October 18, 2022
Via
Benzinga
Recap: Synlogic Q2 Earnings
August 11, 2022
Synlogic (NASDAQ:SYBX) reported its Q2 earnings results on Thursday, August 11, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Earnings Scheduled For August 11, 2022
August 11, 2022
Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.
Via
Benzinga
Recap: Synlogic Q1 Earnings
May 12, 2022
Synlogic (NASDAQ:SYBX) reported its Q1 earnings results on Thursday, May 12, 2022 at 06:30 AM. Here's what investors need to know about the announcement.
Via
Benzinga
BP To Rally Around 22%? Plus This Analyst Predicts $47 For YETI
November 11, 2022
Piper Sandler boosted the price target on BP p.l.c. (NYSE: BP) from $37 to $40. BP shares rose 1.9% to close at $32.95 on Thursday.
Via
Benzinga
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
August 23, 2022
Via
Benzinga
FDA Grants Fast Track Status To Synlogic's Rare Genetic Disorder Drug
August 23, 2022
Synlogic, Inc. (NASDAQ: SYBX) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its drug candidate SYNB1353 for the potential treatment of homocystinuria...
Via
Benzinga
What Is Going on With Ginkgo Bioworks (DNA) Stock Today?
August 12, 2022
DNA stock and other small biotech plays are rising on speculation about drugs like its candidate against gout.
Via
InvestorPlace
Why Ginkgo Bioworks Stock Is Soaring Today
August 11, 2022
Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading higher Thursday after Synlogic Inc (NASDAQ: SYBX) announced a new drug candidate for the treatment of gout, which is being developed in...
Via
Benzinga
Recap: Synlogic Q4 Earnings
March 17, 2022
Synlogic (NASDAQ:SYBX) reported its Q4 earnings results on Thursday, March 17, 2022 at 06:30 AM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
August 01, 2022
On Monday, 92 companies set new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
July 26, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
July 12, 2022
Gainers Guardant Health (NASDAQ:GH) stock rose 14.8% to $55.23 during Tuesday's after-market session. The market value of their outstanding shares is at $5.6 billion.
Via
Benzinga
Synlogic Initiates Initial-Stage Homocystinuria Study
July 12, 2022
Synlogic (NASDAQ: SYBX) has dosed its first healthy volunteer in its Phase 1 study of the investigational oral therapy SYNB1353 for the potential treatment of homocystinuria (HCU).
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
June 23, 2022
Via
Benzinga
22 Stocks Moving in Thursday's Pre-Market Session
June 23, 2022
Gainers WISeKey International Holding AG (NASDAQ: WKEY) rose 74.4% to $2.32 in pre-market trading. WISeKey International recently issued 2022 first-half revenue guidance for its IoT segment.
Via
Benzinga
89 Biggest Movers From Friday
June 21, 2022
Gainers Revlon, Inc. (NYSE: REV) jumped 91.3% to close at $3.73 on Friday after the company filed for Chapter 11 bankruptcy.
Via
Benzinga
Synlogic's Return On Capital Employed Overview
June 16, 2022
Benzinga Pro data, Synlogic (NASDAQ:SYBX) reported Q1 sales of $224.00 thousand. Earnings fell to a loss of $15.70 million, resulting in a 4.03% decrease from last quarter.
Via
Benzinga
Synlogic Earnings Preview
May 11, 2022
Synlogic (NASDAQ:SYBX) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Synlogic will...
Via
Benzinga
The Week Ahead In Biotech (May 1-7): Phathom FDA Decision, Pfizer, Vertex Pharma Lead Earnings News, Ophthalmology Conference Presentations, And More
May 02, 2022
Biotech stocks posted weekly declines yet again in the week ending April 29, taking cues from the weak broader market sentiment. Big pharma earnings, clinical readouts and pipeline updates moved stocks...
Via
Benzinga
Synlogic's Return On Capital Employed Overview
March 18, 2022
According to data from Benzinga Pro, during Q4, Synlogic's (NASDAQ:SYBX) reported sales totaled $592.00 thousand. Despite a 5.79% increase in earnings, the company posted a loss...
Via
Benzinga
Earnings Scheduled For May 12, 2022
May 12, 2022
Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its first quarter.
Via
Benzinga
10 Biggest Price Target Changes For Friday
March 18, 2022
Keybanc cut the price target on AMETEK, Inc. (NYSE: AME) from $160 to $155. AMETEK shares rose 1% to close at $132.75 on Thursday.
Via
Benzinga
The Daily Biotech Pulse: AbbVie's Rinvoq Gets Label Expansion, AstraZeneca COVID Antibody Cocktail Authorized By UK Regulator, Stealth Touts Positive Data
March 17, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Earnings Preview For Synlogic
March 16, 2022
Synlogic (NASDAQ:SYBX) is set to give its latest quarterly earnings report on Thursday, 2022-03-17. Here's what investors need to know before the announcement. Analysts estimate...
Via
Benzinga
The Daily Biotech Pulse: NuCana Shelves Biliary Tract Cancer Study, Tricida Data Readout Pushed Back Due to Ukrainian Crisis, Synlogic Names New CFO
March 03, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus NuCana Discontinues Biliary Tract Cancer Study Following Futility Analysis...
Via
Benzinga
Earnings Scheduled For March 17, 2022
March 17, 2022
Companies Reporting Before The Bell • TransGlobe Energy (NASDAQ:TGA) is estimated to report earnings for its fourth quarter. • Ikena Oncology (NASDAQ:IKNA) is...
Via
Benzinga
The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings
March 13, 2022
Biotech stocks pulled back for a second week running, as the Ukraine war cast its cloud on the broader market. Dwindling earnings news flow and company-specific developments...
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.